This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Rosa, S. C. Articles by Roederer, M. Search for Related Content PubMed PubMed Citation Articles by De Rosa, S. C. Articles by Roederer, M.

(Journal of Leukocyte Biology. 2001;70:518-526.)
© 2001 by Society for Leukocyte Biology

V1 and V2 T cells express distinct surface markers and might be developmentally distinct lineages

Stephen C. De Rosa^*, Dipendra K. Mitra, Nobukazu Watanabe, Leonore A. Herzenberg, Leonard A. Herzenberg and Mario Roederer^*

^* Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, and
Department of Genetics, Stanford University Medical School, Stanford, California

Correspondence: Stephen C. De Rosa, M.D., Vaccine Research Center, National Institutes of Health, 40 Convent Drive, Room 5612, Bethesda, MD 20814. E-mail: SDeRosa{at}nih.gov

We report here that the two major types of T cells found in human blood, V1 and V2, were found to have markedly different phenotypes. V2 cells had a phenotype typical of most ß T cells in blood; i.e., they were CD5⁺, CD28⁺, and CD57^-. In contrast, V1 cells tended to be CD5^-/dull, CD28^-, and CD57⁺. Furthermore, although V1 T cells appeared to be "naive" in that they were CD45RA⁺, they were CD62L^- and on stimulation uniformly produced interferon-, indicating that they are in fact memory/effector cells. This phenotype for V1 cells was similar to that of intestinal intraepithelial lymphocytes, a subset that can develop in the absence of the thymus. We suggest that the V1 and V2 T cell subsets represent distinct lineages with different developmental pathways. The disruption of the supply of normal, thymus-derived T cells in HIV-infected individuals might be responsible for the shift in the V2/V1 ratio that occurs in the blood of individuals with HIV disease.

Key Words: intestinal intraepithelial lymphocytes • CD5 • FACS

This article has been cited by other articles:

				J.-S. Cummings, C. Cairo, C. Armstrong, C. E. Davis, and C. D. Pauza Impacts of HIV infection on V{gamma}2V{delta}2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS J. Leukoc. Biol., August 1, 2008; 84(2): 371 - 379. [Abstract] [Full Text] [PDF]

				S. Barcy, S. C. De Rosa, J. Vieira, K. Diem, M. Ikoma, C. Casper, and L. Corey {gamma}{delta}+ T Cells Involvement in Viral Immune Control of Chronic Human Herpesvirus 8 Infection J. Immunol., March 1, 2008; 180(5): 3417 - 3425. [Abstract] [Full Text] [PDF]

				I Tikhonov, C. Deetz, R Paca, S Berg, V Lukyanenko, J. Lim, and C. Pauza Human V{gamma}2V{delta}2 T cells contain cytoplasmic RANTES Int. Immunol., August 1, 2006; 18(8): 1243 - 1251. [Abstract] [Full Text] [PDF]

				S. C. De Rosa, J. P. Andrus, S. P. Perfetto, J. J. Mantovani, L. A. Herzenberg, L. A. Herzenberg, and M. Roederer Ontogeny of {gamma}{delta} T Cells in Humans J. Immunol., February 1, 2004; 172(3): 1637 - 1645. [Abstract] [Full Text] [PDF]

				M. A. Poles, S. Barsoum, W. Yu, J. Yu, P. Sun, J. Daly, T. He, S. Mehandru, A. Talal, M. Markowitz, et al. Human Immunodeficiency Virus Type 1 Induces Persistent Changes in Mucosal and Blood {gamma}{delta} T Cells despite Suppressive Therapy J. Virol., October 1, 2003; 77(19): 10456 - 10467. [Abstract] [Full Text] [PDF]